Since 2004, the Publications Committee has been charged with developing and publishing various publications, including the SMFM Consult Series and the SMFM Clinical Guidelines series published in the American Journal of Obstetrics & Gynecology. The Publications Committee collaborates with other Societies and Colleges to develop joint publications and statements, as appropriate. The Committee plans topics, selects authors, and reviews each completed paper before it is submitted for an internal SMFM review process and then for publication. All Committee members have filed conflict of interest statements with SMFM. Any conflicts have been resolved through a process approved by the Executive Board. To facilitate transparency in SMFM's guideline development process, a brief overview of the key stages in development is provided here. Feedback for SMFM Publications is welcome at pubs@smfm.org
Abstract: Up to 1 in 5 childbearing people experience mental health conditions as a complication of pregnancy. Mental health conditions, including suicide and overdose, are the leading causes of death in the first postpartum year and are 100% preventable. Most people who experience perinatal... Continue Reading
Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Continue Reading
The Society for Maternal-Fetal Medicine endorses this Clinical Practice Update. Continue Reading
The Society for Maternal-Fetal Medicine acknowledges gun violence as a public health crisis in the United States, with a substantial impact on pregnant and postpartum people. Continue Reading
The Society for Maternal-Fetal Medicine supports the right of all individuals to access the full spectrum of reproductive health services, including abortion care. Continue Reading
Position: The Society for Maternal-Fetal Medicine supports federal and state policies that expand Medicaid eligibility and extend Medicaid coverage through 12 months postpartum to address the maternal morbidity and mortality crisis and improve health equity. Access to coverage is essential to... Continue Reading
Abstract This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No.... Continue Reading
Abstract More than 290 million people worldwide, and almost 2 million people in the United States, are infected with hepatitis B virus, which can lead to chronic hepatitis B, a vaccine-preventable communicable disease. The prevalence of chronic hepatitis B infection in pregnancy is estimated to... Continue Reading
Measles, also known as rubeola, is a preventable, highly contagious, acute febrile viral illness and an important cause of mortality and morbidity. As of March 21, 2024, 64 measles cases have been reported by 17 jurisdictions (Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana,... Continue Reading
Abstract Pregnant individuals with sickle cell disease have an increased risk of maternal and perinatal morbidity and mortality. However, pre-pregnancy counseling and multidisciplinary care can lead to favorable maternal and neonatal outcomes. In this Consult, we summarize what is known about... Continue Reading
Heath care measurement and evaluation is an integral piece of the health care system. The creation and assessment of care performance metrics are important and relevant for the obstetric community including both clinicians and patients. Careful deliberation is required to create a measurement... Continue Reading
Abstract: Guidelines for the management of first-trimester spontaneous and induced abortion vary regarding RhD testing and Rho(D) immune globulin administration. These existing guidelines are based on limited data that do not convincingly demonstrate the safety of withholding Rho(D) immune... Continue Reading
